LAVA Therapeutics NV 4 SEC Filings

Filed On	Filing
17 Nov 2025	Form 4: Noble James, Director Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Powell Fred M, Chief Financial Officer Returned 65,000 shares to the issuer · Disposed of 124,700 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Wadlinger Mary E., Director Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Oliger Christy J., Director Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Kiener Peter A, Director Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Backstrom Jay T., Director Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Wilson Karen J, Director Returned 10,000 shares to the issuer · Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Dhingra Kapil, Director Returned 30,000 shares to the issuer · Disposed of 33,390 Share Options (Right to Buy) (Disposition to Issuer)
17 Nov 2025	Form 4: Hurly Stephen A, Director Returned 5,000 shares to the issuer · Disposed of 335,100 Share Options (Right to Buy) (Disposition to Issuer)
20 Oct 2025	Form 4: Cooperatieve Gilde Healthcare Iv U.a., 10% owner and 1 other Sold 1,000,000 shares ($1.46M) · Sold 690,239 shares ($1.03M) · Sold 1,181,131 shares ($1.74M)
15 Oct 2025	Form 4: Cooperatieve Gilde Healthcare Iv U.a., 10% owner and 1 other Sold 200,000 shares ($302K) · Sold 47,686 shares ($73.4K) · Sold 227,341 shares ($343K)
10 Oct 2025	Form 4: Cooperatieve Gilde Healthcare Iv U.a., 10% owner and 1 other Sold 28,954 shares ($45.5K) · Sold 48,169 shares ($75.1K) · Sold 49,869 shares ($77.3K)
23 Sep 2025	Form 4: Versant Venture Capital VI, L.p., 10% owner and 5 others Sold 2,903,403 shares ($4.07M)
18 Sep 2025	Form 4: Versant Venture Capital VI, L.p., 10% owner and 5 others Sold 500,000 shares ($767K) · Sold 589,532 shares ($878K) · Sold 594,902 shares ($858K)
18 Feb 2025	Form 4: Wilson Karen J, Director Granted 33,390 Common Shares (Right to Buy)
18 Feb 2025	Form 4: Wadlinger Mary E., Director Granted 33,390 Common Shares (Right to Buy)
18 Feb 2025	Form 4: Noble James, Director Granted 33,390 Common Shares (Right to Buy)
18 Feb 2025	Form 4: Kiener Peter A, Director Granted 33,390 Common Shares (Right to Buy)
18 Feb 2025	Form 4: Backstrom Jay T., Director Granted 33,390 Common Shares (Right to Buy)
18 Feb 2025	Form 4: Dhingra Kapil, Director Granted 33,390 Common Shares (Right to Buy)

Comments